MedTrace Logo

Outcomes of TAMIS-Total Mesorectal Excision Versus Transanal Loco-regional Excision for T2 Low Rectal Cancer

NCT02488577 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2018-09-12

No results posted yet for this study

Summary

Cases with stage T2 N0 low rectal cancer will undergo either Transanal minimally invasive total mesorectal excision or transanal minimally invasive locoregional resection.

Conditions

  • Low Rectal Cancer

Interventions

PROCEDURE

Transanal minimally invasive total mesorectal excision

PROCEDURE

transanal minimally invasive locoregional resection

Sponsors & Collaborators

  • Osama Mohammad Ali ElDamshety

    lead OTHER

Principal Investigators

  • Sherif Kotb, M.D., PhD. · Professor of surgical oncology Mansoura university

  • Osama Eldamshety, PhD · surgical oncology Mansoura university

  • Adel Fathi, M.D. · surgical oncology Mansoura university

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2019-06-30
Completion
2019-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02488577 on ClinicalTrials.gov